Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Leukocyte Biology|January 21, 2021
Myeloid-derived suppressor cells and their association with vaccine immunogenicity in South African infantsElvis Kidzeru, Melanie A Gasper, Danica Shao, et al.
The Journal of Clinical Investigation|March 30, 2021
B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skinEmily S Ford, Anton M Sholukh, RuthMabel Boytz, et al.
The Journal of Clinical Investigation|June 4, 2024
Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiationJaimy Joy, Ana Gervassi, Lennie Chen, et al.
The Pediatric Infectious Disease Journal|November 1, 2024
Infectious Morbidity and All-cause Mortality of Infants HIV-exposed Uninfected Compared to Infants HIV-unexposed Uninfected in BotswanaMelanie M Dubois, Jennifer Jao, Shan Sun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2023
T-SPOT.TB Reactivity in Southern African Children With and Without in Utero Human Immunodeficiency Virus ExposureSaori C Iwase, Paul T Edlefsen, Lynnette Bhebhe, et al.
The Journal of Clinical Investigation|March 22, 2022
Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapyBenjamin D Varco-Merth, William Brantley, Alejandra Marenco, et al.
Plos Pathogens|August 22, 2024
Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistenceBenjamin Varco-Merth, Morgan Chaunzwa, Derick M Duell, et al.
Science Immunology|June 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccineScott G Hansen, Meaghan H Hancock, Daniel Malouli, et al.
Plos Pathogens|July 6, 2021
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacyFredrik Barrenäs, Scott G Hansen, Lynn Law, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2024
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence featuresMichal Juraska, Hongjun Bai, Allan C deCamp, et al.
Pageof 2